Withanolide D Exhibits Similar Cytostatic Effect in Drug-Resistant and Drug-Sensitive Multiple Myeloma Cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Withanolide D Exhibits Similar Cytostatic Effect in Drug-Resistant and Drug-Sensitive Multiple Myeloma Cells
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-09-08
DOI
10.3389/fphar.2017.00610
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Withaferin A induces cell death and differentiation in multiple myeloma cancer stem cells
- (2017) Mark E. Issa et al. MedChemComm
- Bruceantin inhibits multiple myeloma cancer stem cell proliferation
- (2016) Mark E. Issa et al. CANCER BIOLOGY & THERAPY
- Multiple myeloma cancer stem cells
- (2016) Minjie Gao et al. Oncotarget
- Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?
- (2015) Reinaldo Franqui-Machin et al. Oncotarget
- The role of P-glycoprotein in drug resistance in multiple myeloma
- (2014) Joseph Abraham et al. LEUKEMIA & LYMPHOMA
- The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance
- (2013) Radosław Januchowski et al. BIOMEDICINE & PHARMACOTHERAPY
- Silencing NOTCH signaling causes growth arrest in both breast cancer stem cells and breast cancer cells
- (2013) S Suman et al. BRITISH JOURNAL OF CANCER
- Myeloma stem cell concepts, heterogeneity and plasticity of multiple myeloma
- (2013) Roman Hajek et al. BRITISH JOURNAL OF HAEMATOLOGY
- The interaction of bortezomib with multidrug transporters: implications for therapeutic applications in advanced multiple myeloma and other neoplasias
- (2013) Robert O’Connor et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Fact or fiction - identifying the elusive multiple myeloma stem cell
- (2013) Joshua Kellner et al. Journal of Hematology & Oncology
- Cancer stem cells: The challenges ahead
- (2013) Jan Paul Medema NATURE CELL BIOLOGY
- Multiple Myeloma: A Paradigm for Translation of the Cancer Stem Cell Hypothesis
- (2012) Jasmin Agarwal et al. Anti-Cancer Agents in Medicinal Chemistry
- Natural Products: Promising Resources for Cancer Drug Discovery
- (2012) Susmita Mondal et al. Anti-Cancer Agents in Medicinal Chemistry
- Investigational ABC transporter inhibitors
- (2012) Marco Falasca et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Epigenetic alterations involved in cancer stem cell reprogramming
- (2012) Purificación Muñoz et al. Molecular Oncology
- Primer3—new capabilities and interfaces
- (2012) Andreas Untergasser et al. NUCLEIC ACIDS RESEARCH
- Bak Compensated for Bax in p53-null Cells to Release Cytochrome c for the Initiation of Mitochondrial Signaling during Withanolide D-Induced Apoptosis
- (2012) Susmita Mondal et al. PLoS One
- Treatment of multiple myeloma
- (2011) S. Vincent Rajkumar Nature Reviews Clinical Oncology
- Antifungal and Cytotoxic Activity of Withanolides fromAcnistus arborescens
- (2010) Vincent Roumy et al. JOURNAL OF NATURAL PRODUCTS
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- (2010) A Singh et al. ONCOGENE
- Normal stem cells and cancer stem cells: similar and different
- (2010) Mark Shackleton SEMINARS IN CANCER BIOLOGY
- The Search for Multiple Myeloma Stem Cells: The Long and Winding Road
- (2009) Grzegorz Wladyslaw Basak et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Steroidal Lactones from Withania somnifera, an Ancient Plant for Novel Medicine
- (2009) Mohammad Mirjalili et al. MOLECULES
- 2,3-Dihydrowithaferin A-3β-O-sulfate, a new potential prodrug of withaferin A from aeroponically grown Withania somnifera
- (2008) Ya-ming Xu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Multiple Myeloma Cancer Stem Cells
- (2008) Carol Ann Huff et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started